Study S000063

Liraglutide and Insulin-001 A Randomized Prospective Trial of Liraglutide Added to High-Dose Insulin Therapy vs. High-Dose Insulin Therapy Alone in Insulin-Resistant Patients With Type 2 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT01654120
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 37
Start: 2011-12
Primary completion: 2013-11
Lead sponsor: Mountain Diabetes and Endocrine Center
Conditions: Diabetes Mellitus, Type II
Interventions: DRUG:Liraglutide; DRUG:Insulin
Results posted: FALSE

Registered primary outcomes

Change from baseline in HbA1c at six months [baseline and six months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.